• New IQS-JEOL NMR Demo Lab

Friday, 02 December, 2022
IQS Tech Transfer

Bruno Achard, Managing Director of JEOL Europa; Salvador Borrós, Director of IQS; and Carlos Arribas, General Manager of Izasa Scientific

IQS will boast a JEOL nuclear magnetic resonance instrument demo laboratory. This new platform will feature two latest generation spectrometers with "High Tech" technologies in terms of digital signals and high frequencies.

The first 400 MHz spectrometer will have a hybrid use for solution NMR and solid-state NMR. Therefore, it will be equipped with the "Royal HFX" probe, which is especially versatile within the context of the pharmaceutical industry, the "3.2 mm HXMAS" probe that enables measuring samples in solid state, and an automatic sample changer that will make it possible to use both for teaching and research work.

The second 600 MHz spectrometer, dedicated more specifically to research, will be equipped, in addition to the "Royal" room temperature probe, with a cryogenic probe cooled with "SuperCool" liquid nitrogen that will make it possible to reach very high sensitivities in a wide range of cores, a particularly interesting feature in biomedical research or in the analysis of biological samples.

This new platform will be possible thanks to the collaboration agreement signed between IQS, JEOL, and Izasa Scientific, the supplier of JEOL instruments in Spain. The new infrastructure will involve the incorporation of IQS's university laboratories into the Japanese multinational's global network of benchmark NMR laboratories.

The alliance forms part of the IQS initiative to create a benchmark NMR laboratory to promote scientific research and technology transfer. In addition to the acquisition of new instruments, the partnership agreement includes the contribution by the three entities to raise awareness and promote this type of joint business-university platform to support synergies with this spectroscopic technique, one of the world's most powerful for determining molecular structures.

In addition, the agreement also establishes the launch of a series of annual demonstrations and presentations by JEOL, the organization of an annual JEOL-IQS NMR Summer School with a scientific programme aimed at training and guiding multiple users on the techniques for the latest advances with these instruments, collaboration with the European Demo Centre (UK) in the adaptation of experiences and the development of new NMR sequences, and the organization of various events such as workshops and user meetings at the IQS campus.

With the incorporation of these new instruments, IQS is increasing and diversifying the services it can offer to companies, thereby collaborating on technological developments in its surroundings as well.

 

Dr Núria Vallmitjana
Director of IQS Tech Transfer